The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
β Scribed by E.K. Tan; H. Shen; L.C.S. Tan; M. Farrer; K. Yew; E. Chua; R.D. Jamora; K. Puvan; K.Y. Puong; Y. Zhao; R. Pavanni; M.C. Wong; Yuen Yih; L. Skipper; Jian-Jun Liu
- Book ID
- 116767839
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 54 KB
- Volume
- 384
- Category
- Article
- ISSN
- 0304-3940
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Posterior cortical atrophy (PCA) represents a degenerative disorder characterized by the development of higherorder visual deficit. 1 PCA may result from heterogeneous pathologies that make up tauopathies. An increasing number of mutations in the tau gene (microtubule-associated protein tau [MAPT])
## Abstract Mutations in the leucineβrich repeat kinase 2 (__LRRK2__) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD). We report here the frequency of a common heterozygous mutation, 2877510G>A, which produces a glycineβtoβserine amino acid substitution at cod
genes and who were found to be negative. 1 In this group of 122 patients, we identified 5 patients with an FMR1 premutation and in 4 of them a definite diagnosis of fragile Xassociated tremor/ataxia syndrome (FXTAS) could be made, based on the proposed diagnostic criteria for FXTAS. We proposed base